Publicaciones en colaboración con investigadores/as de Tongji University (2)

2016

  1. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial

    Annals of Oncology, Vol. 27, Núm. 3, pp. 417-423

2010

  1. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): A phase 4 study

    The Lancet Oncology, Vol. 11, Núm. 8, pp. 733-740